Tobacco use as contributory factor in peptic ulcer disease

Journal of the College of Physicians and Surgeons Pakistan

Volumn 13, Issue 7, 2003, Pages 385-387

  Rahman Afridi, Mohammad Abdur ^a  

^a LADY READING HOSPITAL   (Pakistan)

Author keywords

Nonsteroidal anti inflammatory drugs (NSAIDs); Oesophagogastroduodenoscopy (OGD); Peptic ulcer disease (PUD); Tobacco, smoking

Indexed keywords

LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEVICE; DIET RESTRICTION; DRUG USE; DUODENUM ULCER; ENDOSCOPE; ENDOSCOPY; FEMALE; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PEPTIC ULCER; RISK FACTOR; SMOKING; STOMACH ULCER; TOBACCO; TOPICAL ANESTHESIA;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; SMOKING;

EID: 0042912875     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Katz J. The course of peptic ulcer disease. Med Clin North Am 1991; 75: 831-40.
2. Valle JD. Peptic ulcer disease and related disorders. In: Braunwald E, Fauci AS, Kasper DL, Houser SL, Longo DL, Jameson JL, (edi). Harrison's principles of internal medicine. 15th edi New York: McGraw-Hill 2001: 1649-65.
3. Soll AH. Duodenal ulcer and drug therapy. In: Sleisenger MH, Fordtran JS, (edi). Gastrointestinal disease pathophysiology diagnosis management. Vol.I. 4th ed. Philadelphia: WB Saunders 1989: 814-79.
4. Richardson CT. Gastric ulcer. In: Sleisenger MH, Fordtran JS, (edi). Gastrointestinal disease: pathophysiology diagnosis management. Vol.I. 4th ed. Philadelphia: WB Saunders 1989: 879-909.
5. Mertz HR, Walsh JH. Peptic ulcer pathophysiology. Med Clin North Am 1991: 75: 799-814.
6. Szabo S, Vattay P. Experimental gastric and duodenal ulcers: advances in pathogenesis. Gastroenterol Clin North Am 1990; 19: 67-86.
7. Pounder R. Peptic ulceration. Med Int 1994; 7: 225-30.
8. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273.
9. Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1:1273-5.
10. Prasher G, Eastwood GL. Smoking and peptic ulcer in the Helicobacter pylori era. Eur J Gastroenterol Hepatol 2000; 12: 843-53.
11. Marshall BJ. McGechie DB, Rogers PA, Glacy RJ. Pyloric campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439-44.
12. Graham DY, Go MF. Helicobacter pylori: current status. Gastronterology 1993; 105: 279-82.
13. Tytgat GN, Rauws EAJ. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 183-96.
14. Lakhwani MN, Ismail, AR, Barras, CD, Tan WJ. Upper gastrointestinal bleeding in Kuala Lumpur Hospital, Malaysia. Med J Malaysia 2000; 55: 498-505.
15. Andersen IB, Jargensen T, Bonnevie O, Gronbaek M, Sorensen T. Smoking and alcohol intake as risk factors for bleeding and perforated ulcers: a population based cohort study. Epidemiology 2000; 11: 434-9.
16. Ko JK, Cho CH. Alcohol drinking and cigarette smoking: a partner for gastric ulceration. Zhonghua Y1 Xue Za Zhi (Taipei) 2000; 63: 845-54.
17. Shimoyama T, Everett SM, Fukuda S, Axon AT, Dixon MF, Crabtree JE. Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol 2001; 54: 332-4.
18. Ahmed W, Qureshi H, Alam ES, Zuberi SJ. Pattern of duodenal ulcer in Karachi. J Pak Med Assoc 1990; 40: 212-5.
19. Tham KT, Peek RM Jr, Atherton JC, Cover TL, Perez-Perez GI, Shyr Y, et al Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol 2001; 32: 264-73.
20. Graham DY. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. Gastroenterol Clin North Am 1990; 19:171-82.
21. Lanas AI, Remacha B, Estava F, Sainz R. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995; 109: 1124-33.
22. Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-78.
23. Moxham J. Smoking. Med Int 1995; 9: 83-6.
24. Endoh K, Leung FW. Effect of smoking and nicotine on the gastric mucosa: a review of clinical and experimental evidence. Gastroenterology 1994; 107: 864-74.
25. Doll R, Jones FA, Pygott F. Effect of smoking on the production and maintenance of gastric and duodenal ulcers. Lancet 1958; 1:657-62.
26. Korman MG, Hansky MG, Hansky J, Eaves ER, Schmidt GT. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 1983; 85: 871-4.
27. Abdur Rahman M, Khan I, Shah MS. Clinical features and endoscopic findings in peptic ulcer. J Postgrad Med Int 1998; 12: 51-9.
28. Kazmi SU, Amjad M, Shahid M, Manzoor H, Quraishy S. A five year study of prevalence of Helicobacter pylori infection in Karachi, Pakistan. J Coll Physicians Surg Pak 1996; 6: 39-42.
29. Ma L, Wang WP, Chow JY, Yuen ST, Cho CH. Reduction of EGF is associated with the delay of ulcer healing by cigarette smoking. Am J Physiol Gastrointest Liver Physiol 2000; 278: 610-7.
30. Levenstein S. Peptic ulcer at the end of the 20th century: biological and psychological risk factors. Can J Gastreoenterol 1999; 13: 753-9.
31. Henry D. Dobson A, Tuner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti inflammatory drugs. Gastroenterology 1993; 105: 1078-88.
32. Weil J, Collin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-30.
33. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, et al. Peptic ulcer bleeding; accessory risk factors and interactions with nonsteroidal anti-inflammatory drugs. Gut 2000; 46: 27-31.